EMAIL THIS PAGE TO A FRIEND

Journal of immunology research

A Humanized Anti-CD22-Onconase Antibody-Drug Conjugate Mediates Highly Potent Destruction of Targeted Tumor Cells.


PMID 26605343

Abstract

Antibody-drug conjugates (ADCs) have evolved as a new class of potent cancer therapeutics. We here report on the development of ADCs with specificity for the B-cell lineage specific (surface) antigen CD22 being expressed in the majority of hematological malignancies. As targeting moiety a previously generated humanized anti-CD22 single-chain variable fragment (scFv) derivative from the monoclonal antibody RFB4 was reengineered into a humanized IgG1 antibody format (huRFB4). Onconase (ranpirnase), a clinically active pancreatic-type ribonuclease, was employed as cytotoxic payload moiety. Chemical conjugation via thiol-cleavable disulfide linkage retained full enzymatic activity and full binding affinity of the ADC. Development of sophisticated purification procedures using size exclusion and ion exchange chromatography allowed the separation of immunoconjugate species with stoichiometrically defined number of Onconase cargos. A minimum of two Onconase molecules per IgG was required for achieving significant in vitro cytotoxicity towards lymphoma and leukemia cell lines. Antibody-drug conjugates with an Onconase to antibody ratio of 3 : 1 exhibited an IC50 of 0.08 nM, corresponding to more than 18,400-fold increased cytotoxicity of the ADC when compared with unconjugated Onconase. These results justify further development of this ADC as a promising first-in-class compound for the treatment of CD22-positive malignancies.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

M6250
2-Mercaptoethanol, ≥99.0%
C2H6OS
M3148
2-Mercaptoethanol, for molecular biology, for electrophoresis, suitable for cell culture, BioReagent, 99% (GC/titration)
C2H6OS
M7154
2-Mercaptoethanol, for electrophoresis
C2H6OS
63689
2-Mercaptoethanol, BioUltra, for molecular biology, ≥99.0% (GC)
C2H6OS
P3415
3-(2-Pyridyldithio)propionic acid N-hydroxysuccinimide ester, ≥95%, powder
C12H12N2O4S2
M5525
4-(N-Maleimidomethyl)cyclohexanecarboxylic acid N-hydroxysuccinimide ester, ≥98%, powder
C16H18N2O6
A3553
Acrylamide, for electrophoresis, ≥99% (HPLC), powder
C3H5NO
A8887
Acrylamide, suitable for electrophoresis, ≥99%
C3H5NO
A9099
Acrylamide, for molecular biology, ≥99% (HPLC)
C3H5NO
A4058
Acrylamide solution, 40%, for electrophoresis, sterile-filtered
C3H5NO
EDS
Ethylenediaminetetraacetic acid, BioUltra, anhydrous, ≥99% (titration)
C10H16N2O8
E6758
Ethylenediaminetetraacetic acid, anhydrous, crystalline, BioReagent, suitable for cell culture
C10H16N2O8
431788
Ethylenediaminetetraacetic acid, 99.995% trace metals basis
C10H16N2O8
E9884
Ethylenediaminetetraacetic acid, ACS reagent, 99.4-100.6%, powder
C10H16N2O8
ED
Ethylenediaminetetraacetic acid, purified grade, ≥98.5%, powder
C10H16N2O8
E8008
Ethylenediaminetetraacetic acid solution, 0.02% in DPBS (0.5 mM), sterile-filtered, BioReagent, suitable for cell culture
C10H16N2O8
46955
Fluorescein, for fluorescence, free acid
C20H12O5
T9281
N,N,N′,N′-Tetramethylethylenediamine, BioReagent, suitable for electrophoresis, ~99%
C6H16N2
T7024
N,N,N′,N′-Tetramethylethylenediamine, BioReagent, for molecular biology, ≥99% (GC)
C6H16N2
411019
N,N,N′,N′-Tetramethylethylenediamine, ≥99.5%, purified by redistillation
C6H16N2
T22500
N,N,N′,N′-Tetramethylethylenediamine, ReagentPlus®, 99%
C6H16N2
S8032
Sodium azide, BioXtra
N3Na
438456
Sodium azide, ≥99.99% trace metals basis
N3Na
S2002
Sodium azide, ReagentPlus®, ≥99.5%
N3Na
71289
Sodium azide, BioUltra, ≥99.5% (T)
N3Na
71290
Sodium azide, purum p.a., ≥99.0% (T)
N3Na
74255
Sodium dodecyl sulfate, dust-free pellets, suitable for electrophoresis, for molecular biology, ≥99.0% (GC)
C12H25NaO4S
L3771
Sodium dodecyl sulfate, BioReagent, suitable for electrophoresis, for molecular biology, ≥98.5% (GC)
C12H25NaO4S
L6026
Sodium dodecyl sulfate, BioXtra, ≥99.0% (GC)
C12H25NaO4S
436143
Sodium dodecyl sulfate, ACS reagent, ≥99.0%
C12H25NaO4S